US2013252347A1PendingUtilityA1
Diagnostic method
Est. expiryJun 12, 2027(~0.9 yrs left)· nominal 20-yr term from priority
G01N 33/6893G01N 2800/26G01N 33/569A61P 31/04A61B 5/00A61K 39/00G01N 33/575
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
It has been demonstrated that the level of HBP increases in individuals that subsequently develop severe sepsis. Accordingly, the level of HBP, HBP/WBC ratio or HBP/NC ratio in an individual can be used to determine whether or not an individual is at risk of developing severe sepsis.
Claims
exact text as granted — not AI-modified1 - 15 . (canceled)
16 . An agent for the detection of HBP for use in determining whether or not an individual is at risk of developing severe sepsis.
17 . An agent according to claim 16 wherein the agent comprises an HBP-specific antibody.
18 - 21 . (canceled)
22 . A test kit for use in a method for determining whether or not an individual is at risk of developing severe sepsis, which test kit comprises an agent for the detection of HBP in an individual.
23 . The kit of claim 21 additionally comprising means for the measurement of the WBC in an individual.Join the waitlist — get patent alerts
Track US2013252347A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.